Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients (NCT07473284) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients
300 participantsStarted 2026-04-01
Plain-language summary
The goal of this observational study is to describe characteristics of catheter related thrombosis (CRT) that persists after catheter extraction in condition of intensive care unit. The main questions it aims to answer are:
1. What is the incidence of CRT that persists after catheter extraction in patients hospitalized in the intensive care unit?
2. What are the risk factors for this phenomenon?
3. What is the fate of such a thrombus, including recanalization or the development of complications such as pulmonary embolism or post-thrombotic syndrome?
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age over 18 years
* ICU hospitalization
* signed informed consent
* an indwelling central venous catheter planned for extraction
Exclusion Criteria:
* age under 18 years
* local pathology precluding ultrasound examination
* disagreement with participation in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is specifically looking at blood clots that stay in the vein even after a catheter is removed — if I've had a central line, how would my doctor check whether I might have this kind of leftover clot?
2Since this trial is observational and focused on measuring how often catheter-related thrombosis persists rather than testing a new treatment, would joining it actually change how my clot is managed, or would I just be monitored and tracked?
3The study lists post-thrombotic syndrome and pulmonary embolism as related conditions — can my doctor explain what my personal risk is for those complications if a clot lingers in my vein after catheter removal?
4This trial hasn't started recruiting yet — given that timing, would it make more sense for me to focus on standard treatment options now, and could I potentially revisit participation once the study opens?
5Because this is a phase-not-applicable observational study in ICU patients, what kinds of follow-up visits or imaging would likely be involved, and how might that fit with my current recovery and care schedule?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of catheter related thrombosis persisting in vein after catheter removal.
Timeframe: Primary outcome will be known after From date of randomization until last patient is enrolled, up to 30.9.2028
Trial details
NCT IDNCT07473284
SponsorMasarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.